Semaglutide and other GLP-1 medications have turned the tide in the battle against obesity
What led you to want to raise awareness about potential issues that could develop when a patient is on a GLP-1 agonist as well as isotretinoin
Food Supplements As with other supplements, seek professional advice before using if you are on medication, pregnant, breast-feeding or suffer from food allergies
Expert consensus suggests considering pharmacotherapy when there is: Significant weight regain from nadir weight BMI 27 kg/m with obesity-related comorbidities or BMI 30 kg/m Absence of anatomical complications requiring surgical revision Adequate adherence to nutritional and behavioral recommendations Patient willingness to engage in long-term pharmacotherapy The American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) guidelines emphasize that pharmacologic therapy should complement, not replace, lifestyle interventions and ongoing bariatric surgical follow-up
triple-agonist glp-1 / gip / glucagon
In fact, sometimes in weight loss patients, the scars will actually turn out a little better [than average], says Dr